Chin Richard — SEC insider filings

SEC reporting owner CIK 1337252. 15 insider filings on record with FilingPulse; latest filed 2026-11-20.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2021-01-20 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Kindred Biosciences, Inc. (KIN)Chief Executive Officer, Director7—3 legs · 120,000 sh · $1,102,58826
Cytek Biosciences, Inc. (CTKB)Director8——16

Insider filings — Chin Richard

FiledFormIssuerReported transactionsSource
2026-11-204Cytek Biosciences, Inc. (CTKB)Option exercise (M): 6,107 · Option exercise (M): 6,107 (derivative) @ $0EDGAR
2026-08-204Cytek Biosciences, Inc. (CTKB)Option exercise (M): 6,107 · Option exercise (M): 6,107 (derivative) @ $0EDGAR
2026-06-124Cytek Biosciences, Inc. (CTKB)Grant/award (A): 33,333 (derivative) @ $0 · Grant/award (A): 18,261 (derivative) @ $0EDGAR
2026-05-204Cytek Biosciences, Inc. (CTKB)Option exercise (M): 6,107 · Option exercise (M): 6,107 (derivative) @ $0EDGAR
2026-03-124Cytek Biosciences, Inc. (CTKB)Option exercise (M): 6,107 · Option exercise (M): 6,107 (derivative) @ $0EDGAR
2025-11-204Cytek Biosciences, Inc. (CTKB)Option exercise (M): 6,107 · Option exercise (M): 6,107 (derivative) @ $0EDGAR
2025-08-204Cytek Biosciences, Inc. (CTKB)Option exercise (M): 4,071 · Option exercise (M): 4,071 (derivative) @ $0EDGAR
2025-06-204Cytek Biosciences, Inc. (CTKB)Grant/award (A): 73,289 (derivative) @ $0 · Grant/award (A): 39,062 (derivative) @ $0EDGAR
2021-08-304Kindred Biosciences, Inc. (KIN)Disposition to issuer (D): 1,709,271 @ $9.25 · Disposition to issuer (D): 2,000 @ $9.25 · Disposition to issuer (D): 2,000 @ $9.25 · Disposition to issuer (D): 2,000 @ $9.25 · Disposition to issuer (D): 2,000 @ $9.25 · Disposition to issuer (D): 400,000 (derivative) @ $8.89 · +8 moreEDGAR
2021-08-044Kindred Biosciences, Inc. (KIN)Gift (G): 320,000 @ $0 · Sale (S): 40,000 @ $9.21EDGAR
2021-07-074Kindred Biosciences, Inc. (KIN)Sale (S): 40,000 @ $9.18EDGAR
2021-06-174Kindred Biosciences, Inc. (KIN)Sale (S): 40,000 @ $9.18EDGAR
2021-02-034Kindred Biosciences, Inc. (KIN)Option exercise (M): 12,500 · Tax withholding (F): 6,582 @ $5 · Option exercise (M): 12,500 (derivative) @ $0EDGAR
2021-01-264Kindred Biosciences, Inc. (KIN)Option exercise (M): 37,500 · Tax withholding (F): 19,744 @ $4.93 · Tax withholding (F): 13,163 @ $4.93 · Option exercise (M): 37,500 (derivative) @ $0EDGAR
2021-01-204Kindred Biosciences, Inc. (KIN)Option exercise (M): 37,500 · Tax withholding (F): 21,128 @ $4.95 · Option exercise (M): 37,500 (derivative) @ $0 · Grant/award (A): 394,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1337252 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs